Literature DB >> 7715834

Immunocytochemical localization of mu-opioid receptor in the rat caudate-putamen.

T Kaneko1, M Minami, M Satoh, N Mizuno.   

Abstract

A guinea pig antibody against a C-terminal peptide of rat mu-opioid receptor (MOR) was produced to examine the distribution of MOR in the rat caudate-putamen (CP). The anti-peptide antibody recognized a protein of M(r) 69,000 in Triton X-100 extract of rat brain and in the membrane fraction of MOR-expressing culture cells. Intense MOR-like immunoreactivity (LI) was observed in island-like areas of the CP. Some MOR-LI was located on the cell bodies and dendrites of CP neurons. Double immunofluorescence study revealed that the intensely MOR-immunoreactive areas showed weak calbindin-LI, surrounded by intensely calbindin-positive regions. The results indicate that MOR-LI is enriched in the 'patches' of the neostriatal mosaic compartmentation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7715834     DOI: 10.1016/0304-3940(94)11192-l

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  15 in total

1.  Involvement of the rat caudate nucleus in the immunostimulatory effect of DAGO.

Authors:  L V Devoino; M A Cheido; E L Al'perina
Journal:  Neurosci Behav Physiol       Date:  2001 May-Jun

2.  Ultrastructural immunocytochemical localization of mu-opioid receptors in rat nucleus accumbens: extrasynaptic plasmalemmal distribution and association with Leu5-enkephalin.

Authors:  A L Svingos; A Moriwaki; J B Wang; G R Uhl; V M Pickel
Journal:  J Neurosci       Date:  1996-07-01       Impact factor: 6.167

3.  Long-term plasticity of corticostriatal synapses is modulated by pathway-specific co-release of opioids through κ-opioid receptors.

Authors:  Sarah L Hawes; Armando G Salinas; David M Lovinger; Kim T Blackwell
Journal:  J Physiol       Date:  2017-05-26       Impact factor: 5.182

4.  Striatal patch compartment lesions alter methamphetamine-induced behavior and immediate early gene expression in the striatum, substantia nigra and frontal cortex.

Authors:  Ryan C Murray; Yamiece E Gilbert; Anna S Logan; John C Hebbard; Kristen A Horner
Journal:  Brain Struct Funct       Date:  2013-04-27       Impact factor: 3.270

5.  Differential LRRK2 expression in the cortex, striatum, and substantia nigra in transgenic and nontransgenic rodents.

Authors:  Andrew B West; Rita M Cowell; João P L Daher; Mark S Moehle; Kelly M Hinkle; Heather L Melrose; David G Standaert; Laura A Volpicelli-Daley
Journal:  J Comp Neurol       Date:  2014-04-12       Impact factor: 3.215

6.  Striatal patch compartment lesions reduce stereotypy following repeated cocaine administration.

Authors:  Ryan C Murray; Mary C Logan; Kristen A Horner
Journal:  Brain Res       Date:  2015-06-19       Impact factor: 3.252

7.  mu-Opioid receptors are localized to extrasynaptic plasma membranes of GABAergic neurons and their targets in the rat nucleus accumbens.

Authors:  A L Svingos; A Moriwaki; J B Wang; G R Uhl; V M Pickel
Journal:  J Neurosci       Date:  1997-04-01       Impact factor: 6.167

8.  Effect of the antidepressant nefazodone on the density of cells expressing mu-opioid receptors in discrete brain areas processing sensory and affective dimensions of pain.

Authors:  Antonio Ortega-Alvaro; Ignacio Acebes; Gonzalo Saracíbar; Enrique Echevarría; Luis Casis; Juan Antonio Micó
Journal:  Psychopharmacology (Berl)       Date:  2004-04-27       Impact factor: 4.530

Review 9.  Roles of micro-opioid receptors in GABAergic synaptic transmission in the striosome and matrix compartments of the striatum.

Authors:  Masami Miura; Masao Masuda; Toshihiko Aosaki
Journal:  Mol Neurobiol       Date:  2008-05-13       Impact factor: 5.590

10.  The absence of endogenous beta-endorphin selectively blocks phosphorylation and desensitization of mu opioid receptors following partial sciatic nerve ligation.

Authors:  M Petraschka; S Li; T L Gilbert; R E Westenbroek; M R Bruchas; S Schreiber; J Lowe; M J Low; J E Pintar; C Chavkin
Journal:  Neuroscience       Date:  2007-04-30       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.